Welcome to our dedicated page for Select Medical news (Ticker: SEM), a resource for investors and traders seeking the latest updates and insights on Select Medical stock.
Overview
Select Medical Holdings Corporation (NYSE: SEM) is a prominent healthcare organization that provides a full continuum of care with a focus on critical illness recovery, rehabilitation, and occupational health services. With a proven track record of clinical quality and operational excellence, Select Medical has built a robust platform in the United States by offering specialized medical recovery solutions and health services. The organization is characterized by its diverse network of facilities and its commitment to delivering patient-first care.
Business Segments and Services
Select Medical operates through four key segments that define its comprehensive service offerings:
- Critical Illness Recovery Hospitals: These facilities cater to patients who have emerged from life-threatening conditions and require extended support to regain their health. They focus on advanced medical care and prolonged recovery services.
- Rehabilitation Hospitals: Designed for inpatient care, these hospitals offer specialized therapies and medical oversight to patients recovering from strokes, spinal cord injuries, brain injuries, orthopedic conditions, and other complex health events.
- Outpatient Rehabilitation Clinics: Through a large network of clinics, Select Medical provides accessible outpatient rehabilitation services encompassing physical therapy, occupational therapy, and specialized recovery programs.
- Occupational Health Centers (Concentra): Focused on workplace and direct-to-employer care, the Concentra segment provides preventive health screenings, injury care, and comprehensive occupational medicine services to support the health and productivity of the workforce.
Operational Excellence and Clinical Commitment
The company maintains its founding principles by emphasizing clinical quality and a patient-first philosophy. Every facility within the Select Medical network reflects the company's core values by striving for optimal patient outcomes and compassionate care. With a strong emphasis on operational efficiency, clinical partnerships, and continuous improvement, Select Medical ensures that every stage of the care journey—from the acute recovery phase to outpatient follow-up—is managed with precision and expertise.
Market Position and Competitive Landscape
In a competitive healthcare market, Select Medical distinguishes itself through its expansive network and integration of recovery and rehabilitation services. The combination of inpatient facilities and outpatient care centers allows Select Medical to offer a seamless continuum of services that meet the diverse needs of patients across the United States. The company's strategic focus on quality, safety, and outcomes underscores its position as a major player in the post-acute care sector. Furthermore, its dedicated approach to recruiting and training top healthcare professionals fortifies its reputation for exceptional care delivery.
Partnerships and Innovative Care Delivery
Select Medical has cultivated numerous joint ventures and partnerships with established healthcare institutions, enhancing its capacity to introduce innovative care models and specialized programs. For instance, collaborations with renowned medical centers underline the company's commitment to integrating advanced technologies and evidence-based practices into its clinical programs. These partnerships not only drive operational improvements but also pave the way for enhanced patient experiences and long-term health benefits.
Commitment to Quality and Community Impact
The foundation of Select Medical's operational strategy lies in its unwavering commitment to improving quality of life. The company’s patient-centric approach is evident in its comprehensive care programs, which are tailored to meet individual recovery needs and promote long-term wellness. Additionally, Select Medical’s extensive presence across multiple states and its continuous investment in clinical excellence underscore its dedication to serving communities and addressing the dynamic healthcare needs of a diverse patient population.
Conclusion
Overall, Select Medical Holdings Corporation exemplifies a robust healthcare model that integrates a variety of post-acute services across critical illness recovery, inpatient and outpatient rehabilitation, and occupational health. Its strategic organization, combined with an evergreen commitment to clinical quality, positions it as a vital component of the U.S. healthcare landscape. This detailed overview serves as a comprehensive resource that encapsulates the company's operational frameworks, industry expertise, and dedication to delivering quality care.
Select Medical Holdings (NYSE: SEM) announced its Q4 and full-year 2024 results, along with its 2025 outlook and dividend declaration. Key highlights include:
The company completed a tax-free distribution of Concentra shares on November 25, 2024. Q4 2024 revenue increased 7.8% to $1,312.6 million, though the company reported a loss from continuing operations of $10.5 million, impacted by a one-time $45.9 million stock compensation expense and $17.9 million debt refinancing loss.
For full-year 2024, revenue grew 7.5% to $5,187.1 million, with income from continuing operations increasing 17.7% to $130.0 million. The board declared a cash dividend of $0.0625 per share, payable March 13, 2025. The company also maintains a $1.0 billion stock repurchase program through December 31, 2025.
The 2025 business outlook projects revenue between $5.4-5.6 billion and Adjusted EBITDA of $520.0-540.0 million.
Select Medical Holdings (NYSE: SEM) has scheduled its fourth quarter and full year 2024 financial results release for Thursday, February 20, 2025, after market close. The company will host a conference call to discuss results and business outlook on Friday, February 21, 2025, at 9:00am ET.
As of December 31, 2024, Select Medical operates 104 critical illness recovery hospitals in 29 states, 35 rehabilitation hospitals in 14 states, and 1,914 outpatient rehabilitation clinics across 39 states and the District of Columbia. The company's operations span 41 states and D.C., making it one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.
Select Medical Holdings (NYSE: SEM) announced that its subsidiary, Select Medical , has completed a private offering of $550.0 million in 6.250% senior notes due 2032. The notes are senior unsecured obligations guaranteed by certain domestic subsidiaries.
The proceeds from the offering, along with new incremental term loan and cash on hand, will be used to repay existing term loans, redeem outstanding 6.250% senior notes due 2026, and cover related fees and expenses. The notes were offered exclusively to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.
Concentra (NYSE: CON) announced the completion of its spin-off from Select Medical through the distribution of 104,093,503 shares, representing 81.7% of Concentra's outstanding common stock. Select Medical stockholders received 0.806971 Concentra shares for each Select Medical share held as of November 18, 2024. Concentra, the largest U.S. occupational health services provider, operates 549 health centers and 156 onsite clinics across 45 states, serving over 50,000 patients daily with 11,000 colleagues and affiliated medical professionals.
Select Medical Holdings (NYSE: SEM) has completed the distribution of 104,093,503 shares (81.7%) of Concentra (NYSE: CON) common stock to its stockholders. The distribution occurred on November 25, 2024, with stockholders receiving 0.806971 Concentra shares for each Select Medical share held as of the November 18, 2024 record date. Following this spin-off, Select Medical no longer holds any Concentra shares. J.P. Morgan and Goldman Sachs served as financial advisors for the distribution.
Select Medical Holdings (NYSE: SEM) has announced the distribution ratio for its special stock distribution of Concentra Group Holdings Parent equity to stockholders. Shareholders will receive 0.806971 shares of Concentra's common stock for each Select Medical share held as of November 18, 2024 (Record Date). The distribution will occur on November 25, 2024, with cash provided in lieu of fractional shares. The distribution is intended to be tax-free for U.S. federal income tax purposes. J.P. Morgan and Goldman Sachs are serving as financial advisors, while Dechert LLP is acting as legal advisor for the distribution.
Select Medical Holdings (NYSE: SEM) announced that its subsidiary, Select Medical , has priced a $550.0 million private offering of 6.250% senior notes due 2032. The offering is expected to close on December 3, 2024. The notes will be senior unsecured obligations guaranteed by certain domestic subsidiaries.
The company plans to use the proceeds, along with a new incremental term loan and cash on hand, to repay existing term loans, redeem outstanding 6.250% senior notes due 2026, and cover related fees. The notes will be offered only to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.
Select Medical Holdings (NYSE: SEM) announced that Select Medical has initiated a private offering of $850 million in senior notes due 2032. The company plans to amend its existing senior secured credit agreement to establish a new incremental term loan and extend its revolving credit facility maturity. The proceeds will be used to repay existing term loans, redeem all outstanding 6.250% senior notes due 2026, and cover related fees. The notes will be offered exclusively to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.
Select Medical Holdings has announced a special stock distribution of its Concentra holdings to shareholders. The distribution will occur on November 25, 2024, with a record date of November 18, 2024. Stockholders will receive approximately 0.806971 shares of Concentra's common stock (NYSE: CON) for each share of Select Medical stock held. The distribution represents about 81.7% of Concentra's outstanding shares, totaling 104,093,503 shares. The transaction is intended to be tax-free for U.S. federal income tax purposes, and no stockholder action is required. Cash will be provided in lieu of fractional shares.
Select Medical Holdings (NYSE: SEM) reported strong Q3 2024 financial results with significant growth across key metrics. Revenue increased 5.7% to $1,761.2 million, while net income rose 33.2% to $81.0 million. The company saw improved performance across all segments, with notable growth in rehabilitation hospitals (14.4% revenue increase) and outpatient rehabilitation (6.9% revenue increase).
The company declared a cash dividend of $0.125 per share, payable around November 26, 2024, to stockholders of record as of November 13, 2024. Additionally, Select Medical updated its 2024 outlook, projecting revenue between $6.95-7.15 billion and Adjusted EBITDA of $865.0-885.0 million.
FAQ
What is the current stock price of Select Medical (SEM)?
What is the market cap of Select Medical (SEM)?
What are the main business segments of Select Medical?
How does Select Medical deliver its healthcare services?
What distinguishes Select Medical’s approach to patient care?
How extensive is Select Medical's network?
What role does the Concentra segment play within the company?
How does Select Medical ensure operational excellence?
What types of recovery services does Select Medical provide?
How does Select Medical's structure benefit the community?
